Arcoxia: Targeted Relief for Chronic Pain and Inflammation
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.41 | $42.22 (0%) | 🛒 Add to cart |
| 60 | $1.06 | $84.43 $63.32 (25%) | 🛒 Add to cart |
| 90 | $0.93 | $126.65 $83.43 (34%) | 🛒 Add to cart |
| 120 | $0.88 | $168.87 $105.54 (38%) | 🛒 Add to cart |
| 180 | $0.82 | $253.30 $146.75 (42%) | 🛒 Add to cart |
| 270 | $0.78 | $379.95 $210.08 (45%) | 🛒 Add to cart |
| 360 | $0.76
Best per pill | $506.60 $272.40 (46%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.27 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $78.40 $70.36 (10%) | 🛒 Add to cart |
| 120 | $0.73 | $104.54 $87.45 (16%) | 🛒 Add to cart |
| 180 | $0.69 | $156.80 $123.63 (21%) | 🛒 Add to cart |
| 270 | $0.66 | $235.21 $177.91 (24%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $313.61 $233.20 (26%) | 🛒 Add to cart |
| Product dosage: 90mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.94 | $56.29 (0%) | 🛒 Add to cart |
| 90 | $0.84 | $84.43 $75.39 (11%) | 🛒 Add to cart |
| 120 | $0.79 | $112.58 $94.48 (16%) | 🛒 Add to cart |
| 180 | $0.73 | $168.87 $131.68 (22%) | 🛒 Add to cart |
| 270 | $0.70 | $253.30 $188.97 (25%) | 🛒 Add to cart |
| 360 | $0.68
Best per pill | $337.73 $245.26 (27%) | 🛒 Add to cart |
Synonyms | |||
Arcoxia (etoricoxib) is a prescription medication belonging to the class of selective COX-2 inhibitors, designed to provide effective management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gout. It functions by specifically inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a key role in the inflammatory process, thereby reducing prostaglandin production without significantly affecting the COX-1 enzyme involved in gastric mucosal protection. This mechanism offers a favorable balance between anti-inflammatory efficacy and gastrointestinal tolerability, making it a valuable option for long-term symptomatic control in appropriate patient populations under medical supervision.
Features
- Active ingredient: etoricoxib
- Available in tablet formulations (30 mg, 60 mg, 90 mg, 120 mg)
- Selective COX-2 inhibitor with minimal effect on COX-1
- Once-daily dosing for consistent therapeutic coverage
- Rapid onset of action with sustained anti-inflammatory and analgesic effects
- Manufactured under strict pharmaceutical quality standards
Benefits
- Provides significant reduction in pain and stiffness associated with chronic inflammatory arthritis
- Improves physical function and mobility, enhancing quality of life
- Lower risk of gastrointestinal complications compared to traditional NSAIDs
- Convenient once-daily dosing supports treatment adherence
- Effective management of acute gouty arthritis attacks
- Demonstrated efficacy in multiple inflammatory conditions with well-established clinical data
Common use
Arcoxia is commonly prescribed for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. It is also used for the relief of acute pain associated with dental surgery and primary dysmenorrhea in appropriate patient populations. The medication is specifically indicated for patients who require long-term anti-inflammatory therapy and may be at risk for gastrointestinal complications with traditional NSAIDs.
Dosage and direction
The recommended dosage of Arcoxia varies depending on the condition being treated:
- Osteoarthritis: 30 mg once daily
- Rheumatoid arthritis: 60 mg once daily
- Ankylosing spondylitis: 90 mg once daily
- Acute gouty arthritis: 120 mg once daily (for maximum 8 days)
Tablets should be taken orally with or without food. The lowest effective dose should be used for the shortest duration possible to control symptoms. Dosage adjustment is recommended for patients with hepatic impairment, elderly patients, and those weighing less than 60 kg. Treatment should be initiated and monitored by a healthcare professional familiar with the patient’s medical history.
Precautions
Patients should be carefully evaluated before prescribing Arcoxia, particularly those with a history of cardiovascular disease, hypertension, heart failure, or cerebrovascular disease. Regular monitoring of blood pressure is recommended during treatment. Use with caution in patients with pre-existing renal or hepatic impairment, dehydration, or hypovolemia. Elderly patients may be more susceptible to adverse reactions. Patients should be advised to report any signs of gastrointestinal bleeding, skin reactions, or edema promptly. Arcoxia may mask fever, which is an important sign of infection.
Contraindications
Arcoxia is contraindicated in patients with:
- Hypersensitivity to etoricoxib or any component of the formulation
- Active peptic ulceration or gastrointestinal bleeding
- Severe hepatic dysfunction (Child-Pugh score ≥9)
- Estimated creatinine clearance <30 mL/min
- Inflammatory bowel disease
- Congestive heart failure (NYHA Class II-IV)
- Established ischemic heart disease, peripheral arterial disease, or cerebrovascular disease
- Pregnancy (third trimester) and breastfeeding
- Children and adolescents under 16 years of age
Possible side effects
Common side effects (≥1/100 to <1/10):
- Headache, dizziness
- Hypertension, edema
- Dyspepsia, abdominal pain, nausea
- Fatigue, flu-like symptoms
Uncommon side effects (≥1/1,000 to <1/100):
- Palpitations, tachycardia
- Gastritis, gastroesophageal reflux disease
- Increased liver enzymes, weight gain
- Anxiety, insomnia, paresthesia
Rare side effects (≥1/10,000 to <1/1,000):
- Angioedema, bronchospasm
- Hepatitis, jaundice
- Renal impairment, interstitial nephritis
- Stevens-Johnson syndrome, toxic epidermal necrolysis
Drug interaction
Arcoxia may interact with:
- Warfarin and other anticoagulants (increased risk of bleeding)
- ACE inhibitors, angiotensin II antagonists, and diuretics (reduced antihypertensive effect)
- Lithium (increased lithium concentrations)
- Methotrexate (increased methotrexate levels)
- Cyclosporine and tacrolimus (increased nephrotoxicity risk)
- Rifampicin (reduced etoricoxib concentrations)
- Oral contraceptives (potential decreased efficacy)
- Other NSAIDs or aspirin (increased risk of adverse effects)
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and continue with the regular dosing schedule. Do not take a double dose to make up for a missed one. If uncertain about proper management of missed doses, consult a healthcare provider.
Overdose
Symptoms of overdose may include lethargy, drowsiness, nausea, vomiting, epigastric pain, gastrointestinal bleeding, hypertension, acute renal failure, and respiratory depression. There is no specific antidote for etoricoxib overdose. Management should include supportive and symptomatic treatment, including gastric lavage if presented within 4 hours of ingestion. Hemodialysis is not likely to be effective due to high protein binding. Monitor and support vital functions as necessary.
Storage
Store at room temperature (15-30°C or 59-86°F) in the original container to protect from moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication according to local regulations, preferably through medication take-back programs.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Arcoxia is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual response to treatment may vary, and the prescribing physician will determine the appropriate dosage and duration based on the patient’s specific condition, medical history, and risk factors. Always follow your healthcare provider’s instructions and report any adverse effects promptly.
Reviews
Clinical studies have demonstrated Arcoxia’s efficacy in managing pain and inflammation across multiple indications. In a 12-week randomized controlled trial involving osteoarthritis patients, etoricoxib 30 mg once daily showed significant improvement in pain scores and physical function compared to placebo (p<0.001). Another study in rheumatoid arthritis patients demonstrated that etoricoxib 60 mg provided comparable efficacy to naproxen 500 mg twice daily with superior GI tolerability. Long-term extension studies have shown maintained efficacy over 52 weeks of treatment. Patient-reported outcomes consistently indicate improvements in quality of life measures, particularly in mobility and daily activities. However, physicians note the importance of careful patient selection and ongoing monitoring due to potential cardiovascular and renal risks associated with long-term use.